BRIEF—John Chiplin to leave Scancell

UK immunotherapy company Scancell Holdings has announced that John Chiplin intends to resign his role as executive chairman and non-executive director of the company for personal reasons.

Dr Chiplin, who has been in the role for six years, will stay on for an interim period until the appointment of a new chair. The search to find one has begun.

He said: “As I plan to hand over the reins to a successor, I will be leaving the company well-financed, with an exciting product pipeline, a strong management team and a high-quality shareholder base. I certainly will continue to remain a supportive shareholder.’’

Other changes announced at Scancell include the departure of Richard Goodfellow, who will retire as non-executive director of the company.